Faculty
Richard A. Elion, MD
Clinical Professor of Medicine
George Washington University
Co-Director, HIV/HCV Clinical Research, Providence Hospital
Washington, DC
Donna E. Sweet, MD, AAHIVS, MACP
Professor of Medicine
University of Kansas School of Medicine-Wichita
Director, KU Wichita Internal Medicine Midtown and Ryan White Programs
Director and Principal Investigator
Kansas AIDS Education and Training Center
Wichita, KS
Independent Peer Reviewer
Barry S. Zingman, M.D.
Professor of Medicine (Infectious Diseases)
Albert Einstein College of Medicine
Medical Director, AIDS Center
Clinical Director, Infectious Diseases
Montefiore Medical Center
Bronx, NY
This activity is supported by an educational grant from Gilead Sciences.
Upon completion of the activity, you will receive a certificate of participation, which you can share with your healthcare professional.
Disclaimer
The information presented in this activity is for educational purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine, Montefiore Medical Center, NovaMed Education, and Gilead Sciences. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
For questions related to this activity, please contact Albert Einstein College of Medicine at cme@montefiore.org or call 718-920-6674.
For technical questions related to this activity, please contact RealCME at http://www.realcme.com/cms/support-center.
Disclosures
The "Conflict of Interest Statement" of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relevant relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.
Albert Einstein College of Medicine also requires that faculty participating in any activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device not yet approved for use in the United States.
Disclosures are as follows:
Faculty
Richard A. Elion, MD
Speakers Bureau: Gilead Sciences Inc., Janssen Pharmaceuticals
Advisory board: Viiv, Gilead Sciences Inc.
Donna E. Sweet, MD, AAHIVS, MACP
Consultant: Pfizer Inc
Speakers Bureau: Gilead Sciences Inc., Janssen Pharmaceuticals Inc.
Grant recipient: Merck & Co.
Independent Clinical Peer Reviewer
Barry S. Zingman, M.D.
No relevant financial relationships with any commercial interests
Planning Committee
Victor B. Hatcher, PhD, and the staff of the Center for Continuing Medical Education of Albert Einstein College of Medicine have no relevant conflict of interest, related directly or indirectly, to this educational activity within the past 12 months.
Kate Evans and the staff of NovaMed Education have disclosed that they or their spouse/life partner do not have any relevant conflict of interest, related directly or indirectly, to this educational activity within the past 12 months.
Brian Hujdich and the staff of HealthHIV have disclosed that they or their spouse/life partner do not have any relevant conflict of interest, related directly or indirectly, to this educational activity within the past 12 months.
There will be no discussion of non-FDA approved uses of products within this activity.